Pinnacle Wealth Planning Services
AQST icon

Pinnacle Wealth Planning Services’s Aquestive Therapeutics AQST Stock Holding History

Pinnacle Wealth Planning Services’s Portfolio AQST Stock Details AQST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		– Sell
-1,598
Closed -$6.65K – 2852
2026
Q2 		$6.65K Hold
1,598
– – ﹤0.01% 2216
2026
Q1 		$6.63K Buy
+1,598
New +$6.48K ﹤0.01% 2168

Other funds holding AQST

Wasatch Advisors
Wasatch Advisors Salt Lake City, Utah $13.5B AUM 16.58% 1-Year Est. Return
Simplify Asset Management
Simplify Asset Management Las Vegas, Nevada $6.11B AUM 3.71% 1-Year Est. Return
Profund Advisors
Profund Advisors Bethesda, Maryland $3.48B AUM 66.96% 1-Year Est. Return
Pavaki Capital Management
Pavaki Capital Management Pueblo, Colorado $294M AUM 34.46% 1-Year Est. Return
Sugar Maple Asset Management
Sugar Maple Asset Management Sister Bay, Wisconsin $175M AUM 16.33% 1-Year Est. Return
Oppenheimer & Co
Oppenheimer & Co New York $9.5B AUM 27.65% 1-Year Est. Return
Penbrook Management
Penbrook Management New York $169M AUM 32.52% 1-Year Est. Return
Trust Point Inc
Trust Point Inc La Crosse, Wisconsin $1.33B AUM 20.56% 1-Year Est. Return
China Universal Asset Management Company
China Universal Asset Management Company Shanghai, China $1.92B AUM 74.14% 1-Year Est. Return
IAIM
International Assets Investment Management Orlando, Florida $1.68B AUM 22.33% 1-Year Est. Return

Pinnacle Wealth Planning Services's AQST Position: Q3 2026 in Review

Pinnacle Wealth Planning Services sold out of Aquestive Therapeutics (AQST) in Q3 2026, closing a stake of 1,598 shares — an estimated $6.65K sold.

Pinnacle Wealth Planning Services first reported a position in AQST in Q1 2026 and held it in 2 quarters. The position peaked at $6.65K in Q2 2026. 34 funds tracked by Wall St. Rank hold AQST as of Q3 2026.

  • Pinnacle Wealth Planning Services reported no remaining Aquestive Therapeutics position as of Q3 2026 after selling out during the quarter.
  • Pinnacle Wealth Planning Services sold 1,598 Aquestive Therapeutics shares in Q3 2026, an estimated $6.65K.
  • Pinnacle Wealth Planning Services first reported a position in Aquestive Therapeutics in Q1 2026 and held it in 2 quarters.
  • Pinnacle Wealth Planning Services's Aquestive Therapeutics position peaked at $6.65K in Q2 2026.
  • 34 funds tracked by Wall St. Rank held Aquestive Therapeutics as of Q3 2026.

Based on Pinnacle Wealth Planning Services's 13F filing for Q3 2026, filed 27 Oct 2026.